PIK3CA and posterior cortical atrophy: More and more evidence suggest that ADT benefits are reduced in PCa with PI3K activation [42, 49], and that combining ADT with PI3K pathway inhibition is significantly more efficient, at least in GEMM, most likely by inhibiting the crosstalk between the two pathways.